Drug Therapy

IRI:
http://www.agfa.com/w3c/2009/drugTherapy
Authors:
Hans Cools, MD; Agfa Healthcare/Belgium
Contributors:
Until 2010: Pieterjan De Potter; Ghent University - IBBT/ELIS - Multimedia Lab/Belgium
Publisher:
Agfa Healthcare/Belgium
Other visualisation:
Ontology source

Abstract

Copyright (c) 2009 Agfa-Gevaert Group and Ghent University - IBBT/ELIS - Multimedia Lab. All Rights Reserved. THIS IS UNPUBLISHED PROPRIETARY SOURCE CODE OF Agfa-Gevaert Group and Ghent University - IBBT/ELIS - Multimedia Lab The copyright notice above does not evidence any actual or intended publication of such source code.

Table of Content

  1. Introduction
  2. Classes
  3. Object Properties
  4. Data Properties
  5. Named Individuals
  6. Annotation Properties
  7. Namespace Declarations

Introduction

Formal general description of clinical drug therapy.

Classes

active immunisationc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#ActiveImmunisation

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
immunisationc

adverse drug reactionc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#AdverseReaction

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
risk factorc

clinical drug administeringc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Administering

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
substance administeringc
has objectop some clinical drug administration formc
wherein administeredop some clinical drug administration formc
has frequencyop some clinical drug administering frequencyc
has outputop some clinical drug administrationc

clinical drug administering frequencyc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#AdministeringFrequency

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
frequencyc
frequency ofop some clinical drug administeringc

clinical drug administrationc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Administration

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
output ofop some clinical drug administeringc
administration ofop some clinical drug administration formc
is in domain of
has dosageop
is in range of
dosage ofop

clinical drug administration formc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#AdministrationForm

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
productc
administrable substancec
containsop some clinical drug productc
is in domain of
administration form ofop, has administration siteop, has units per packagedp
is in range of
has administration formop

clinical drug administration form dosage quantityc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#DosageQuantity

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. 3 (x 1) tablets, 3 x 5 ml (= 3 tsp) (sirup).
has super-classes
error2416c
is in range of
has dosage quantityop

clinical drug administration form quantityc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#AdministrationFormQuantity

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. 3 tablets.
has super-classes
physical quantityc
has measurementop only has unitop some clinical drug administration form unit

clinical drug combination packagec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#CombiPackage

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
productc
containsop min 2
containsop some clinical drug packagec

clinical drug compoundc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Compound

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
clinical drug productc
has active partop min 2

clinical drug deliveredc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Delivery

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
deliveryc
wherein deliveredop some clinical drug packagec
output ofop some clinical drug deliveringc

clinical drug deliveringc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Delivering

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
deliveringc
procedurec
has recipientop some patientc
has donorop some pharmacistc
has outputop only clinical drug deliveredc

clinical drug delivery conditionc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#DeliveryCondition

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
conditionc
is in range of
has delivery conditionop
has members
free of prescriptionni, narcotic delivery conditionni, subject to prescriptionni, subject to prescription with exceptionsni

clinical drug dosagec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Dosage

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. 3 (x 1) tablets, 3 x 5 ml sirup (= 3 tsp sirup).
is in domain of
dosage ofop, has administration formop, has dosage quantityop
is in range of
administration form ofop, has dosageop

clinical drug market statec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#MarketState

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
is equivalent to
{ clinical drug on market , clinical drug approval suspended , clinical drug pulled off market , clinical drug pulled off market by company , clinical drug out of market , clinical drug market state unknown }
is in range of
has market stateop
has members
clinical drug approval suspendedni, clinical drug market state unknownni, clinical drug on marketni, clinical drug out of marketni, clinical drug pulled off marketni, clinical drug pulled off market by companyni

clinical drug packagec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Package

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
productc
containsop some clinical drug package unitc
is in domain of
has administration instructionsdp, has delivery conditionop, has market stateop, has refillsdp, prescribed forop
is in range of
got prescribedop

clinical drug package unitc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#PackageUnit

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. tablet, ampoule, infusion bag, bottle.
has super-classes
productc
containsop some clinical drug administration formc

clinical drug package unit quantityc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#PackageUnitQuantity

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. an injection solution available in 3 milliliter.
has super-classes
error2417c

clinical drug prescribingc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Prescribing

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
prescribingc
has outputop only clinical drug prescriptionc

clinical drug prescriptionc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Prescription

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. R/ Glucophage 500 mg; DT/ 1 package 60 tablets; S/ 3 x 1 tablet/day.
has super-classes
prescriptionc
wherein prescribedop some clinical drug dosagec
wherein prescribedop some clinical drug packagec
wherein prescribedop some clinical drug administering frequencyc
output ofop some clinical drug prescribingc

clinical drug productc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Product

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
Clinical drug usually produced by a pharmaceutical company.
has super-classes
compoundc
productc
contained byop some clinical drug administration formc
has sub-classes
clinical drug compoundc
is in domain of
has active partop, has excipientop
is in range of
active part ofop, excipient ofop

clinical drug product excipientc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Excipient

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
substancec
is in domain of
excipient ofop
is in range of
has excipientop

clinical drug product excipient rolec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#ExcipientRole

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
rolec

clinical drug rolec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Role

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
diagnostic rolec
preventive rolec
therapeutic rolec
role played byop some clinical drug substancec

clinical drug strengthc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Concentration

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
concentrationc
is in range of
has concentrationop

clinical drug substancec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Substance

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
drug substancec
substancec
plays roleop some clinical drug rolec
has sub-classes
experimental clinical drugc
is in domain of
active part ofop, affectsop, has concentrationop, has generic namedp
is in range of
affectsop, has active partop, has affected drugop, has affecting drugop, interaction ofop, wherein administeredop

clinical drug therapyc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Therapy

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
therapyc
has sub procedureop some clinical drug administeringc
has sub-classes
monodrug therapyc, polydrug therapyc
is in domain of
wherein administeredop

drug interactingc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Interacting

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
interactingc
has agentop some clinical drug substancec
has outputop some drug interactionc
is in domain of
has affected drugop, has affected drug interaction stateop, has affecting drugop, has affecting drug interaction stateop

drug interactionc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Interaction

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
interactionc
output ofop some drug interactingc
has objectop some findingc
is in domain of
interaction ofop

experimental clinical drugc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#ExperimentalSubstance

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
clinical drug substancec

immunisationc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Immunisation

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
is equivalent to
primary preventingc and clinical drug therapyc
has sub-classes
active immunisationc

interaction statec back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#InteractionState

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
is equivalent to
{ interaction unknown , interaction unlikely , interaction documented , interaction expected }
is in range of
has affected drug interaction stateop, has affecting drug interaction stateop
has members
interaction documentedni, interaction expectedni, interaction unknownni, interaction unlikelyni

monodrug therapyc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Monotherapy

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
clinical drug therapyc

polydrug therapyc back to ToC or Class ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#Polytherapy

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-classes
clinical drug therapyc

Object Properties

active part ofop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#activePartOf

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

administration form ofop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#administrationFormOf

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

affectsop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#affects

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

dosage ofop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#dosageOf

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

excipient ofop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#excipientOf

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
contained byop
has domain
clinical drug product excipientc
has range
clinical drug productc
is inverse of
has excipientop

got prescribedop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#gotPrescribed

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
got prescribedop
has domain
plays roleop some patientc
has range
clinical drug packagec

has active partop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasActivePart

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
has active partop
has domain
clinical drug productc
has range
clinical drug substancec
is inverse of
active part ofop

has administration formop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAdministrationForm

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has administration siteop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAdministrationSite

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has domain
clinical drug administration formc
has range
structurec

has affected drugop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAffectedDrug

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has affected drug interaction stateop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAffectedDrugInteractionState

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has affecting drugop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAffectingDrug

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has affecting drug interaction stateop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAffectingDrugInteractionState

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has concentrationop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasConcentration

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
has physical quantityop
has domain
clinical drug substancec
has range
clinical drug strengthc

has delivery conditionop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasDeliveryCondition

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has dosageop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasDosage

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

has dosage quantityop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasDosageQuantity

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
has physical quantityop
has domain
clinical drug dosagec
has range
clinical drug administration form dosage quantityc

has excipientop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasExcipient

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
containsop
has domain
clinical drug productc
has range
clinical drug product excipientc
is inverse of
excipient ofop

has market stateop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasMarketState

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

interaction ofop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#interactionOf

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#

prescribed forop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#prescribedFor

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
prescribed forop
has domain
clinical drug packagec
has range
plays roleop some patientc

wherein administeredop back to ToC or Object Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#whereinAdministered

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has domain
clinical drug therapyc
has range
clinical drug substancec
has sub-property chains
has sub procedureop o wherein administeredop o containsop o has active partop

Data Properties

has administration instructionsdp back to ToC or Data Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasAdministrationInstructions

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
E.g. '30 min before breakfast'.
has domain
clinical drug packagec
has range
literal

has generic namedp back to ToC or Data Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasGenericName

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has domain
clinical drug substancec
has range
literal
is also defined as
annotation property

has refillsdp back to ToC or Data Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasRefills

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has domain
clinical drug packagec
has range
non negative integer

has units per packagedp back to ToC or Data Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasUnitsPerPackage

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has domain
clinical drug administration formc
has range
non negative integer

Named Individuals

clinical drug administration form unitni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#administrationFormUnit

belongs to
unitc

clinical drug approval suspendedni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#approvalSuspended

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug market statec

clinical drug market state unknownni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#marketStateUnknown

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug market statec

clinical drug on marketni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#onMarket

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug market statec

clinical drug out of marketni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#outOfMarket

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug market statec

clinical drug pulled off marketni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#pulledOffMarket

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug market statec

clinical drug pulled off market by companyni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#pulledOffMarketByCompany

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug market statec

free of prescriptionni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#freeOfPrescription

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug delivery conditionc

interaction documentedni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#interactionDocumented

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
interaction statec

interaction expectedni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#interactionExpected

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
interaction statec

interaction unknownni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#interactionUnknown

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
interaction statec

interaction unlikelyni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#interactionUnlikely

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
interaction statec

milligram per capsuleni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#milligramPerCapsule

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
unitc
unit defined by productc

milligram per tabletni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#milligramPerTablet

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
unitc
unit defined by productc

narcotic delivery conditionni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#narcoticDeliveryCondition

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug delivery conditionc

per capsuleni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#perCapsule

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
unit derived by raising to powerc

per tabletni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#perTablet

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
unit derived by raising to powerc

subject to prescriptionni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#subjectToPrescription

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug delivery conditionc

subject to prescription with exceptionsni back to ToC or Named Individual ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#subjectToPrescriptionWithExceptions

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
belongs to
clinical drug delivery conditionc

Annotation Properties

definitionap back to ToC or Annotation Property ToC

IRI: http://www.w3.org/2004/02/skos/core#definition

exact matchap back to ToC or Annotation Property ToC

IRI: http://www.w3.org/2004/02/skos/core#exactMatch

has base unitap back to ToC or Annotation Property ToC

IRI: http://sweet.jpl.nasa.gov/2.3/relaSci.owl#hasBaseUnit

has generic nameap back to ToC or Annotation Property ToC

IRI: http://www.agfa.com/w3c/2009/drugTherapy#hasGenericName

is defined by
http://www.agfa.com/w3c/2009/drugTherapy#
has super-properties
nameap
is also defined as
data property

has operandap back to ToC or Annotation Property ToC

IRI: http://sweet.jpl.nasa.gov/2.3/relaMath.owl#hasOperand

in schemeap back to ToC or Annotation Property ToC

IRI: http://www.w3.org/2004/02/skos/core#inScheme

nameap back to ToC or Annotation Property ToC

IRI: http://xmlns.com/foaf/0.1/name

has sub-properties
has generic nameap

noteap back to ToC or Annotation Property ToC

IRI: http://www.w3.org/2004/02/skos/core#note

to the powerap back to ToC or Annotation Property ToC

IRI: http://sweet.jpl.nasa.gov/2.3/relaMath.owl#toThePower

unit ofap back to ToC or Annotation Property ToC

IRI: http://eulersharp.sourceforge.net/2003/03swap/quantities#unitOf

Namespace Declarations back to ToC

default namespace
http://www.agfa.com/w3c/2009/drugTherapy#
2009
http://www.agfa.com/w3c/2009/
agent
http://eulersharp.sourceforge.net/2003/03swap/agent#
clinicalevaluation
http://www.agfa.com/w3c/2009/clinicalEvaluation#
clinicalobservation
http://www.agfa.com/w3c/2009/clinicalObservation#
clinicalprocedure
http://www.agfa.com/w3c/2009/clinicalProcedure#
clinicalskosschemes
http://www.agfa.com/w3c/2009/clinicalSKOSSchemes#
dc
http://purl.org/dc/elements/1.1/
drugTherapy
http://www.agfa.com/w3c/2009/drugTherapy#
drugadministrationforms
http://www.agfa.com/w3c/2009/drugAdministrationForms#
error
http://org.semanticweb.owlapi/error#
event
http://eulersharp.sourceforge.net/2003/03swap/event#
foaf
http://xmlns.com/foaf/0.1/
healthcare
http://www.agfa.com/w3c/2009/healthCare#
humanbody
http://eulersharp.sourceforge.net/2003/03swap/humanBody#
humanriskfactors
http://www.agfa.com/w3c/2009/humanRiskFactors#
owl
http://www.w3.org/2002/07/owl#
physicalresource
http://eulersharp.sourceforge.net/2003/03swap/physicalResource#
quantities
http://eulersharp.sourceforge.net/2003/03swap/quantities#
rdf
http://www.w3.org/1999/02/22-rdf-syntax-ns#
rdfs
http://www.w3.org/2000/01/rdf-schema#
relaMath
http://sweet.jpl.nasa.gov/2.3/relaMath.owl#
relaSci
http://sweet.jpl.nasa.gov/2.3/relaSci.owl#
reprsciunits-owl
http://sweet.jpl.nasa.gov/2.3/reprSciUnits.owl#
skos
http://www.w3.org/2004/02/skos/core#
space
http://eulersharp.sourceforge.net/2003/03swap/space#
therapy
http://www.agfa.com/w3c/2009/therapy#
units
http://eulersharp.sourceforge.net/2003/03swap/units#
xsd
http://www.w3.org/2001/XMLSchema#

This HTML document was obtained by processing the OWL ontology source code through LODE, Live OWL Documentation Environment, developed by Silvio Peroni.